Table 4.
Results of treatment methods.
| Pharmacotherapy [N (%)] | 34 (58.6) |
| Baclofen | 22 (37.9) |
| Trihexyphenidyl | 15 (25.9) |
| Clonazepam | 5 (8.6) |
| Chinese medicine | 5 (8.6) |
| Tiapride | 4 (6.9) |
| Etizolam | 4 (6.9) |
| Zolpidem | 3 (5.2) |
| Others | 3 (5.2) |
| Muscle afferent block therapy | 19 (32.8) |
| Lateral pterygoid (inferior head) | 13 (22.4) |
| Masseter | 9 (15.5) |
| Genioglossus | 4 (6.9) |
| Digastric (posterior belly) | 3 (5.2) |
| Temporalis | 2 (3.4) |
| Risorius | 2 (3.4) |
| Platysma | 1 (1.7) |
| Medial pterygoid | 1 (1.7) |
| Trapezius | 1 (1.7) |
| Botulinum toxin therapy | 28 (48.3) |
| Masseter | 14 (24.1) |
| Lateral pterygoid (inferior head) | 12 (20.7) |
| Temporalis | 9 (15.5) |
| Medial pterygoid | 5 (8.6) |
| Genioglossus | 4 (6.9) |
| Zygomatic major | 4 (6.9) |
| Risorius | 3 (5.2) |
| Digastric (posterior belly) | 2 (3.4) |
| Platysma | 2 (3.4) |
| Trapezius | 2 (3.4) |
| Others | 4 (6.9) |
| Sensory trick splint therapy | 16 (27.6) |
| Surgical therapy (coronoidotomy) | 1 (1.7) |